Post by
BaytexBull on Jul 19, 2016 9:30am
um hum...
Script data from RBC releaed July 18 shows drugs they sell in North American all down (even recognizing that it was a shortened week). That makes me cautious expecting for too much in Q2. I think a longer term approach has to be taken if you want to hold this stock and if you believe that the company will continue to meet its debt obligations. The balance sheet is not great.
Comment by
Kisu on Jul 19, 2016 10:09am
Summer holidays - people have stocked up, not complaining about ailments that can wait until Sept, and Dr's not available. Lower sales to be expected.
Comment by
CdnNewby on Jul 19, 2016 10:14am
From past posts I'm thinking BaytexBull, are you and your buddy Pro Trader both not shorts? Are you actually holding this stock long term?